why choose us

300×250 Ad Slot

Research Article: Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer

Date Published: 2024-01-17

Introduction:
Triple-negative breast cancer (TNBC) is a subtype of breast cancer. It is heterogeneous and does not express estrogen receptor, progesterone receptor, or human epidermal growth factor-. The incidence of TNBC is approximately –% of breast cancer in Western countries and .% in China. , TNBC is characterized by a poor prognosis and high recurrence, metastasis, and mortality rates. – Cytotoxic drugs taxane and anthracycline are the main treatment for triple-negative breast cancer, but patients have became resistant to…

Read more

300×250 Ad Slot